153 related articles for article (PubMed ID: 9394068)
1. Mucin-like carcinoma associated antigen (MCA) at presentation with breast cancer.
Horgan PG; Byrne J; O'Donoghue J; Mooney E; Grimes H; Given HF
Ir J Med Sci; 1997; 166(4):215-6. PubMed ID: 9394068
[TBL] [Abstract][Full Text] [Related]
2. Serum MCA, CA 125 and CA 19.9 determination in primary breast cancer.
Yenisey C; Güner G
Biochem Soc Trans; 1996 May; 24(2):302S. PubMed ID: 8736960
[No Abstract] [Full Text] [Related]
3. Mucin-like carcinoma-associated antigen (MCA) in breast cancer: clinical experience at the National Cancer Institute of Milan.
Seregni E; Crippa F; Botti C; Bellotti MG; Bogni A; Pizzichetta M; Bombardieri E
Int J Biol Markers; 1993; 8(2):124-9. PubMed ID: 8366295
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer.
Rasoul-Rockenschaub S; Zielinski CC; Kubista E; Vavra N; Pospischil E; Staffen A; Czerwenka K; Aiginger P; Spona J
Eur J Cancer Clin Oncol; 1989 Jul; 25(7):1067-72. PubMed ID: 2759162
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.
Eskelinen M; Hippeläinen M; Kettunen J; Salmela E; Penttilä I; Alhava E
Anticancer Res; 1994; 14(2B):699-703. PubMed ID: 8010729
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of mucin-like associated antigen (MCA) in neoplasms of the mammary gland].
Kopczyński Z; Stachowicz A; Kociałkowski K; Grodecka-Gazdecka S
Ginekol Pol; 1993 Feb; 64(2):87-92. PubMed ID: 8359732
[TBL] [Abstract][Full Text] [Related]
7. MCA performance in preoperative breast cancer patients.
Donadeo A; Micelli G; Quaranta M; Atlante A; Schittulli F
Anticancer Res; 1995; 15(2):527-9. PubMed ID: 7763034
[TBL] [Abstract][Full Text] [Related]
8. Cancer associated serum antigen (CASA) levels in patients with breast carcinoma and in 3 control groups without breast cancer.
Meisel M; Weise J; Schwesinger G; Straube W
Arch Gynecol Obstet; 1998; 261(3):159-62. PubMed ID: 9651660
[TBL] [Abstract][Full Text] [Related]
9. The value of tissue polypeptide specific antigen TPS determination in serum of women with breast cancer comparison to mucin-like associated antigen MCA and CA 15-3 antigen.
Kopczyński Z; Thielemann A
Eur J Gynaecol Oncol; 1998; 19(5):503-7. PubMed ID: 9863926
[TBL] [Abstract][Full Text] [Related]
10. Mucin-like cancer-associated antigen (MCA) compared with CA 15-3 in advanced breast cancer.
Steger GG; Mader R; Derfler K; Moser K; Dittrich C
Klin Wochenschr; 1989 Aug; 67(16):813-7. PubMed ID: 2796251
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of mucin-like carcinoma associated antigen (MCA) in breast cancer.
Cooper EH; Forbes MA; Hancock AK; Price JJ; Parker D
Br J Cancer; 1989 May; 59(5):797-800. PubMed ID: 2736216
[TBL] [Abstract][Full Text] [Related]
12. Mucin-like carcinoma-associated antigen (MCA) in tissue and serum of patients with breast cancer: clinical applications in prognosis and disease monitoring.
Molina R; Jo J; Filella X; Zanon G; Grau JJ; Joseph J; Bedini JL; Biete A; Ballesta AM
Int J Biol Markers; 1993; 8(2):113-23. PubMed ID: 8366294
[TBL] [Abstract][Full Text] [Related]
13. The diagnostic value of CA 27-29, CA 15-3, mucin-like carcinoma antigen, carcinoembryonic antigen and CA 19-9 in breast and gastrointestinal malignancies.
Frenette PS; Thirlwell MP; Trudeau M; Thomson DM; Joseph L; Shuster JS
Tumour Biol; 1994; 15(5):247-54. PubMed ID: 7991985
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of a mucin-like carcinoma-associated antigen in monitoring breast cancer patients in comparison with CA 15-3.
Miserez AR; Günes I; Müller-Brand J; Walther E; Fridrich R; Mäcke H
Eur J Cancer; 1991; 27(2):126-31. PubMed ID: 1827273
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of the new tumor marker MCA in the follow-up of patients with mammary carcinoma.
Müller-Brand J; Mäcke H
Int J Biol Markers; 1993; 8(2):130-2. PubMed ID: 8366296
[TBL] [Abstract][Full Text] [Related]
16. Circulating CA 549 and other associated antigens in breast cancer patients.
Pavesi F; Lotzniker M; Scarabelli M; Mauro E; Visconti G; Nicolato E; Moratti R
Oncology; 1994; 51(1):18-21. PubMed ID: 8265097
[TBL] [Abstract][Full Text] [Related]
17. [Mucin-like carcinoma-associated antigen: sensitivity and specificity in metastatic breast cancer].
Ammon A; Eiffert H; Alhusen R; Weber M; Rümelin B; Groh E; Bartsch H; Marschner N; Nagel GA; Krieger G
Onkologie; 1990 Jun; 13(3):210-4. PubMed ID: 2204009
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of potential usefulness of CEA, CA 15-3, and MCA in follow-up of breast cancer patients.
Jezersek B; Cervek J; Rudolf Z; Novaković S
Cancer Lett; 1996 Dec; 110(1-2):137-44. PubMed ID: 9018092
[TBL] [Abstract][Full Text] [Related]
19. Simple method for comparing reliability of two serum tumour markers in breast carcinoma.
O'Brien DP; Gough DB; Skehill R; Grimes H; Given HF
J Clin Pathol; 1994 Feb; 47(2):134-7. PubMed ID: 8132827
[TBL] [Abstract][Full Text] [Related]
20. Preliminary study on serum levels of mucinous like cancer antigen (MCA) in patients with breast disease: comparison with CEA.
Boccardo F; Bombardieri E; Zanardi S; Valenti G; Zanaboni F; Valtolina M; Seregni E; Crippa F
Int J Biol Markers; 1991; 6(1):12-20. PubMed ID: 1856512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]